Dan McKay is the founder of ReSOLVETM and Head of Computational Chemistry at Ventus Therapeutics. Dan has over 24 years of industry experience in drug discovery, including previously at Novartis and the Merck Frosst Centre for Therapeutic Research. He is a co-author of over 45 publications and over 24 patents.
Dan received his B.Sc. in Chemistry and M.Sc. in Theoretical Chemistry from Carleton University in Professor James Wright’s group.